IV TRC105: Phase I/II started

Tracon began an open-label, U.S. Phase I/II trial to evaluate 10 or 15 mg/kg IV TRC105 every 2 weeks for 24 weeks in combination with oral Afinitor everolimus and oral Femara letrozole in about 35 p...